Corrigendum to: Pre-treatment with the synthetic antioxidant T-butyl bisphenol protects cerebral tissues from experimental ischemia reperfusion injury (Journal of Neurochemistry, (2014), 130, 6, (733-747), 10.1111/jnc.12747);Pre-treatment with the synthetic antioxidant T-butyl bisphenol protects cerebral tissues from experimental ischemia reperfusion injury

Journal of Neurochemistry

Volumn 130, Issue 6, 2014, Pages 733-747

  Duong, Thi Thuy Hong ^a   Chami, Belal ^b   McMahon, Aisling C ^a   Fong, Genevieve M ^b   Dennis, Joanne M ^b   Freedman, Saul B ^a   Witting, Paul K ^a,c  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

antioxidant; apoptosis; neuroprotection; polyphenol; stroke

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ANTIOXIDANT; DITERT BUTYL BISPHENOL; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; 3,3',5,5' TETRA TERT BUTYL 4,4' BISPHENOL; 3,3',5,5'-TETRA-TERT-BUTYL-4,4'-BISPHENOL; BENZHYDRYL DERIVATIVE; CASPASE 3; CASPASE 7; PHENOL DERIVATIVE; POLYPHENOL; THIOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; GENE EXPRESSION; IN VIVO STUDY; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; THERAPY EFFECT; ACUTE PHASE RESPONSE; ANIMAL; BLOOD PRESSURE; BRAIN; CEREBRAL ARTERY DISEASE; DIET; DRUG EFFECT; ENERGY METABOLISM; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NICK END LABELING; OXIDATION REDUCTION REACTION; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING; WISTAR RAT;

ANTIOXIDANT; APOPTOSIS; NEUROPROTECTION; POLYPHENOL; STROKE;

ACUTE-PHASE REACTION; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BENZHYDRYL COMPOUNDS; BLOOD PRESSURE; BLOTTING, WESTERN; BRAIN; CASPASE 3; CASPASE 7; DIET; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENERGY METABOLISM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; PHENOLS; RATS; RATS, WISTAR; REPERFUSION INJURY; STROKE; SULFHYDRYL COMPOUNDS;

EID: 84908233293     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.14343     Document Type: Erratum

References (68)

1. Anderson M. F., and, Sims N. R., (2002) The effect of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions. J. Neurochem. 81, 541-549.
2. Azzi A., (2007) Molecular mechanism of alpha-tocopherol action. Free Radic. Biol. Med. 43, 16-21.
3. Baranova O., Miranda L. F., Pichiule P., Dragatsis I., Johnson R. S., and, Chavez J. C., (2007) Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J. Neurosci. 27, 6320-6332.
4. Barnhart R. L., Busch S. J., and, Jackson R. L., (1989) Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation. J. Lipid Res. 30, 1703-1710.
5. Behl C., and, Moosmann B., (2002) Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. J. Biol. Chem. 383, 521-536.
6. Bohacek I., Cordeau P., Lalancette-Hébert M., Gorup D., Weng Y. C., Gajovic S., and, Kriz J., (2012) Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J. Neuroinflammation 9, 191 (open access).
7. Bonova P., Burda J., Danielisova V., Nemethova M., and, Gottlieb M., (2013) Development of a pattern in biochemical parameters in the core and penumbra during infarct evolution after transient MCAO in rats. Neurochem. Int. 62, 8-14.
8. Cao X., and, Phillis J. W., (1994) alpha-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644, 267-272.
9. Chen H., Song Y. S., and, Chan P. H., (2009) Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J. Cereb. Blood Flow Metab. 29, 1262-1272.
10. Davalos A., (2005) Thrombolysis in acute ischaemic stroke: successes, failures, and new hopes. Cerebrovasc. Dis. 2, 135-139.
11. Davis A. S., Zhao H., Sun G. H., Sapolsky R. M., and, Steinberg G. K., (2007) Gene therapy using SOD1 protects striatal neurons from experimental stroke. Neurosci. Lett. 411, 32-36.
12. Dikalov S., (2011) Crosstalk between mitochondria and NADPH oxidases. Free Radic. Biol. Med. 51, 1289-1301.
13. Doré S., Sampei K., Goto S., et al,. (1999) Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol. Med. 5, 656-663.
14. Duong T. T., Antao S., Ellis N. A., Myers S. J., and, Witting P. K., (2008) Supplementation with a synthetic polyphenol limits oxidative stress and enhances neuronal cell viability in response to hypoxia-re-oxygenation injury. Brain Res. 1219, 8-18.
15. Guo W., Zingg J. M., Meydani M., and, Azzi A., (2007) Alpha-tocopherol counteracts ritonavir-induced proinflammatory cytokines expression in differentiated THP-1 cells. BioFactors 31, 171-179.
16. Huang J., Agus D. B., Winfree C. J., et al,. (2001) Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc. Natl Acad. Sci. USA 98, 11720-11724.
17. 2 in vitro. Brain Res. 671, 181-186.
18. Ji H., Miao J., Zhang X., Du Y., Liu H., Li S., and, Li L., (2012) Inhibition of sonic hedgehog signaling aggravates brain damage associated with the down-regulation of Gli1, Ptch1 and SOD1 expression in acute ischemic stroke. Neurosci. Lett. 506, 1-6.
19. Kawase M., Murakami K., Fujimura M., Morita-Fujimura Y., Gasche Y., Kondo T., Scott R. W., and, Chan P. H., (1999) Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. Stroke 30, 1962-1968.
20. Kelly P. J., Morrow J. D., Ning M., et al,. (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the biomarker evaluation for antioxidant therapies in stroke (BEAT-stroke) study. Stroke 39, 100-104.
21. Kinouchi H., Epstein C. J., Mizui T., Carlson E., Chen S. F., and, Chan P. H., (1991) Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl Acad. Sci. USA 88, 11158-11162.
22. Kleinschnitz C., Grund H., Wingler K., et al,. (2010) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 8, e1000479.
23. Kondo T., Reaume A. G., Huang T. T., Carlson E., Murakami K., Chen S. F., Hoffman E. K., Scott R. W., Epstein C. J., and, Chan P. H., (1997) Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci. 17, 4180-4189.
24. Lapchak P. A., and, Zivin J. A., (2003) Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator. Stroke 34, 2013-2018.
25. Lapchak P. A., and, Zivin J. A., (2009) The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator. Exp. Neurol. 215, 95-100.
26. Lee D. R., Helps S. C., Macardle P. J., Nilsson M., and, Sims N. R., (2009) Alterations in membrane potential in mitochondria isolated from brain subregions during focal cerebral ischemia and early reperfusion: evaluation using flow cytometry. Neurochem. Res. 34, 1857-1866.
27. Leinonen J. S., Ahonen J. P., Lönnrot K., Jehkonen M., Dastidar P., Molnár G., and, Alho H., (2000) Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 31, 33-39.
28. Liu J., Narasimhan P., Yu F., and, Chan P. H., (2005) Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36, 1264-1269.
29. Liu S., Zhang L., Wu Q., Wu Q., and, Wang T., (2013) Chemokine CCL2 induces apoptosis in cortex following traumatic brain injury. J. Mol. Neurosci. 51, 1021-1029.
30. Lonn E., Bosch J., Yusuf S., et al,. (2005) HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293, 1338-1347.
31. Lyerly M. J., Albright K. C., Boehme A. K., et al,. (2014) Safety of protocol violations in acute stroke tPA administration. J. Stroke Cerebrovasc. Dis. 23, 855-860.
32. Margaill I., Plotkine M., and, Lerouet D., (2005) Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 39, 429-443.
33. Matsuda S., Umeda M., Uchida H., Kato H., and, Araki T., (2009) Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischaemia in rats. J. Neural Transm. 116, 395-404.
34. McMahon A. C., Duong T. T. H., Brieger D., and, Witting P. K., (2006) Is there potential for antioxidants to enhance thrombolysis therapy in patients with ischemic stroke? Future Cardiol. 2, 659-665.
35. Morita-Fujimura Y., Fujimura M., Yoshimoto T., and, Chan P. H., (2001) Superoxide during reperfusion contributes to caspase-8 expression and apoptosis after transient focal stroke. Stroke 32, 2356-2361.
36. Nagayama T., Lan J., Henshall D. C., Chen D., O'Horo C., Simon R. P., and, Chen J., (2000) Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J. Neurochem. 75, 1716-1728.
37. Nemeikaite-Ceniene A., Imbrasaite A., Sergediene E., and, Cenas N., (2005) Quantitative structure-activity relationships in prooxidant cytotoxicity of polyphenols: role of potential of phenoxyl radical/phenol redox couple. Arch. Biochem. Biophys. 441, 182-190.
38. Noshita N., Sugawara T., Lewén A., Hayashi T., and, Chan P. H., (2003) Copper-zinc superoxide dismutase affects Akt activation after transient focal cerebral ischemia in mice. Stroke 34, 1513-1518.
39. Polidori M. C., Frei B., Cherubini A., Nelles G., Rordorf G., Keaney J. F., Jr, Schwamm L., Mecocci P., Koroshetz W. J., and, Beal M. F., (1998) Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic. Biol. Med. 25, 561-567.
40. Puyal J., Ginet V., and, Clarke P. G., (2013) Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection. Prog. Neurobiol. 105, 24-48.
41. Radermacher K. A., Wingler K., Langhauser F., Altenhöfer S., Kleikers P., Hermans J. J., Hrabě de Angelis M., Kleinschnitz C., and, Schmidt H. H., (2013) Neuroprotection After Stroke by Targeting NOX4 as a Source of Oxidative Stress. Antioxid. Redox Signal. 18, 1418-1427.
42. Rayner B. S., Wu B.-J., Raftery M., Stocker R., and, Witting P. K., (2005) Human S-nitroso-oxymyoglobin is a store of vasoactive nitric oxide. J. Biol. Chem. 280, 9985-9993.
43. Rayner B. S., Duong T. T., Myers S. J., and, Witting P. K., (2006) Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J. Neurochem. 97, 211-221.
44. Satoh T., Okamoto S.-I., Cui J., Watanabe Y., Furuta K., Suzuki M., Tohyama K., and, Lipton S. A., (2006) Activation of the Keap/Nrf2 pathway for neuroprotection by electrophilic phase II inducers. Proc. Natl Acad. Sci. 103, 768-773.
45. Sergediene E., Jönsson K., Szymusiak H., Tyrakowska B., Rietjens I. M., and, Cenas N., (1999) Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationships. FEBS Lett. 462, 392-396.
46. Sesso H. D., Buring J. E., Christen W. G., Kurth T., Belanger C., MacFadyen J., Bubes V., Manson J. E., Glynn R. J., and, Gaziano J. M., (2008) Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300, 2123-2133.
47. Shah Z. A., Nada S. E., and, Doré S., (2011) Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection. Neuroscience 180, 248-255.
48. Shanu A., Parry S. N., Wood S., Rodas E., and, Witting P. K., (2010) The synthetic polyphenol tert-butyl-bisphenol inhibits myoglobin-induced dysfunction in cultured kidney epithelial cells. Free Radic. Res. 4, 843-853.
49. Shichinohe H., Kuroda S., Yasuda H., Ishikawa T., Iwai M., Horiuchi M., and, Iwasaki Y., (2004) Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res. 1029, 200-206.
50. Shuaib A., Lees K. R., Lyden P., Grotta J., Davalos A., Davis S. M., Diener H. C., Ashwood T., Wasiewski W. W., and, Emeribe U., (2007) NXY-059 for the treatment of acute ischaemic stroke. N. Engl. J. Med. 357, 562-571.
51. Siddiq A., Aminova L. R., and, Ratan R. R., (2007) Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochem. Res. 32, 931-946.
52. Sims N. R., and, Muyderman H., (2010) Mitochondria, oxidative metabolism and cell death in stroke. Biochim. Biophys. Acta 1802, 1880.
53. Strong K., Mathers C., and, Bonita R., (2007) Preventing stroke:saving lives around the world. Lancet Neurol. 6, 182-187.
54. Sugawara T., and, Chan P. H., (2003) Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid. Redox Signal. 5, 597-607.
55. Sutherland G. T., Chami B., Youssef P., and, Witting P. K., (2013) Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product? Redox Rep. 18, 134-141.
56. Thomas S. R., Schulz E., and, Keaney J. F., Jr, (2006) Hydrogen peroxide restrains endothelium-derived nitric oxide bioactivity-role for iron-dependent oxidative stress. Free Radic. Biol. Med. 41, 681-688.
57. Van der Worp H. B., Bar P. R., Kapepelle L. J., and, de Wildt D. J., (1998) Dietary vitamin E levels affect outcome of permanent focal cerebral ischaemia in rats. Stroke 29, 1002-1006.
58. Witting P. K., Westerlund C., and, Stocker R., (1996) A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids. J. Lipid Res. 37, 853-867.
59. Witting P. K., Mohr D., and, Stocker R., (1998) Assessment of the Pro- and antioxidant activity of vitamin E in human low density lipoprotein and plasma. Methods Enzymol. 299, 362-375.
60. Witting P. K., Pettersson K., Ostlund-Lindqvist A. M., Westerlund C., Eriksson A. W., and, Stocker R., (1999a) Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J. 13, 667-675.
61. Witting P., Pettersson K., Ostlund-Lindqvist A. M., Westerlund C., Wâgberg M., and, Stocker R., (1999b) Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. J. Clin. Invest. 104, 213-220.
62. Witting P. K., Wu B. J., Raftery M., Southwell-Keely P., and, Stocker R., (2005) Probucol protects against hypochlorite-induced endothelial dysfunction: identification of a novel pathway of probucol oxidation to a biologically active intermediate. J. Biol. Chem. 280, 15612-15618.
63. Witting P. K., Rayner B. S., Wu B. J., Ellis N. A., and, Stocker R., (2007) Hydrogen peroxide promotes endothelial dysfunction by stimulating multiple sources of superoxide anion radical production and decreasing nitric oxide bioavailability. Cell. Physiol. Biochem. 20, 255-268.
64. Wu C. M., McLaughlin K., Lorenzetti D. L., Hill M. D., Manns B. J., and, Ghali W. A., (2007) Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch. Intern. Med. 167, 2417-2422.
65. Yamagata K., Tagami M., and, Yamori Y., (2010) Neuronal vulnerability of stroke-prone spontaneously hypertensive rats to ischemia and its prevention with antioxidants such as vitamin E. Neuroscience 170, 1-7.
66. Yamashita T., Kamiya T., Deguchi K., Inaba T., Zhang H., Shang J., Miyazaki K., Ohtsuka A., Katayama Y., and, Abe K., (2009) Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. J. Cereb. Blood Flow Metab. 29, 715-725.
67. Zeynalov E., Shah Z. A., Li R. C., and, Doré S., (2009) Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. Neurobiol. Dis. 35, 264-269.
68. Zhang W., Sato K., Hayashi T., Omori N., Nagano I., Kato S., Horiuchi S., and, Abe K., (2004) Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol. Res. 26, 342-348.